(MedPage Today) — LAS VEGAS — GLP-1-based therapies may offer benefits in inflammatory bowel disease (IBD) that extend beyond their metabolic indication, according to two

Engineering of marker-free lettuce chloroplast genome to express CTB-Exenatide and CTB-Lixisenatide for oral delivery. Upper panel: Chemically synthesised exenatide or lixisenatide require expensive production, purification,

Five ways weight-loss jabs are changing spending habits  BBC Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus  NBC News Gut-friendly foods: GLP-1 drives

The Seven Deadly Sins of Weight Loss Drugs by Alan Cassels at Brownstone Institute O is for Obesity…. Back in the days, we saw a

Key Points Some Medicare costs are going up — which is no suprise. Some costs, though, including some prescription drug costs, are going down. Original

Fractyl Health is developing a shot that would program the body to make more of the GLP-1 hormone naturally, a risky bet that it can

Have we reached peak pessimism with Greggs‘ (LSE:GRG) shares? I ask because the FTSE 250 stock’s crashed 47% since August 2024, leaving Greggs languishing near

Victoza, ​approved by the US ⁠Food and Drug Administration in 2010, was Novo’s first-generation blockbuster GLP-1 drug

Novo Nordisk’s weight loss pill is off to an impressive start after less than three weeks on the market. Prescriptions are quickly ramping up, increasing

Fairfax, Va.-based George Mason University is leading a phase 2 clinical trial of ARD-201, an oral medication designed to help patients maintain weight loss after

“I never, ever thought that this would happen.”

Sun Pharmaceutical Industries announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of

Who would have ever thought that a weight loss injectable would become a household name and pop culture-adjacent phenomenon? Ozempic has become synonymous with modern

Richard M Lee/Shutterstock Consumers are surrounded by food that is highly conducive to weight gain. No one likes dieting and very few have lasting success.

Many patients may keep off lost pounds after stopping a GLP-1, US data suggests  Reuters

GLP-1 medications can create opportunity for change—but environment determines what lasts. Discover how context shapes habits more than motivation alone.

In a reminder of the money still available for enticing obesity assets, Corxel Pharmaceuticals has raised $287 million in series D funds to bankroll phase

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two

Since its 2019 founding, Corxel Pharmaceuticals has evolved from focusing on the China market to eyeing the world. The biopharma, founded in Shanghai but now

In 2024, the US Centers for Disease Control and Prevention published “what could well be the most important table in modern public health”, said Tom

China-rooted Corxel raises up to $287M for GLP-1 pill with global ambitions  Endpoints News

WICHITA FALLS, Texas, Jan. 22, 2026 /PRNewswire/ — CoreAge Rx, a telehealth pharmacy specializing in weight management solutions, today announced a pricing structure designed to

The US group has re-hired former CEO Joe Scalzo as sales falter and as GLP-1 trend presents opening for Atkins brand.

6 New Weight Loss Drugs That Could Dethrone Ozempic  Gizmodo What difference will a GLP-1 pill make? Wisconsin weight loss physician weighs in  wpr.org Powerful New Weight-Loss

Insilico Medicine, a U.S.-based, Hong Kong-listed AI drug discovery company, is launching a new service that will train general-purpose large language models, like OpenAI’s GPT

As millions quit GLP-1 drugs and weight rebounds faster than expected, food makers face rising pressure around nutrition, trust and mental health.

Research has found that natural compounds could affect GLP-1

Good morning, everyone, and welcome to the middle of the holiday-shortened week on this side of the pond. Congratulations on making it this far, and remember

THURSDAY, Jan. 22, 2026 — With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2

2026-01-22T11:00:00.000Z Save this storySave this story Save this storySave this story In the new Ryan Murphy horror thriller “The Beauty,” a virus turns its hosts

As GLP-1 use rises, research and experts warn the post-drug phase may be a critical window for weight gain, metabolic instability and unexpected pregnancies

Shanghai-based Hua Medicine wants to capture a greater share of the global diabetes market with a different approach from popular GLP-1 medicines. Many newer diabetes

Many patients may keep off lost pounds after stopping a GLP-1, US data suggests (www.reuters.com) 19:17  

Swiss healthcare group Galenica generated sales of CHF4.14 billion in the previous financial year, an increase of 5.5%. + Get the most important news from

Feeding a high-fat diet (HFD) did not alter body composition or inflammatory outcomes but resulted in impaired regulatory T cell response and compromised adaptive immunity

‘It only makes sense that the weight of passengers impacts costs,’ an equity analyst for a financial firm said

Most patients receiving a GLP-1 receptor agonist (RA) and a biologic continue co-therapy for over a year with few treatment-related adverse events. Medscape Medical News